A randomized double-blind placebo-controlled trial of Guanfacine Extended Release for aggression and self-injurious behavior associated with Prader-Willi Syndrome

Deepan Singh, Michael Silver, Theresa Jacob
doi: https://doi.org/10.1101/2024.08.22.24312419

Article Information

doi 
https://doi.org/10.1101/2024.08.22.24312419
History 
  • August 22, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Deepan Singh1,*,
  2. Michael Silver2 and
  3. Theresa Jacob1,3
  1. 1Department of Psychiatry, Maimonides Medical Center, Brooklyn, New York
  2. 2Research Administration, Maimonides Medical Center, Brooklyn, New York
  3. 3Clinical and Translational Research Labs, Maimonides Medical Center, Brooklyn, New York
  1. ↵*Corresponding Author, Email: desingh{at}maimo.org (DS)
Back to top
Posted August 22, 2024.
Download PDF
Data/Code
Email
A randomized double-blind placebo-controlled trial of Guanfacine Extended Release for aggression and self-injurious behavior associated with Prader-Willi Syndrome
Deepan Singh, Michael Silver, Theresa Jacob
medRxiv 2024.08.22.24312419; doi: https://doi.org/10.1101/2024.08.22.24312419
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area